Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

APPSPIRE App in Preventing Students From Smoking

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01967082
Recruitment Status : Active, not recruiting
First Posted : October 22, 2013
Last Update Posted : August 20, 2019
Sponsor:
Collaborators:
National Cancer Institute (NCI)
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

Brief Summary:
This trial studies how well APPSPIRE, a smartphone app, works in preventing students from smoking. Technology-driven intervention programs, such as the APPSPIRE app, have the potential to increase access to health behavior treatments and therapies, such as tobacco cessation support, and provide effective prevention messaging.

Condition or disease Intervention/treatment Phase
Cigarette Smoker Current Every Day Smoker Student Behavioral: APPSPIRE Behavioral: Focus Group Other: Survey Administration Not Applicable

Detailed Description:

PRIMARY OBJECTIVES:

I. Develop a prototype of the APPSPIRE (phone application [app] of a smoking prevention interactive experience).

II. At post assessment, students enrolled in the study will qualitatively provide information about the usability and usefulness for the prevention and cessation sites.

III. Investigate frequency of use of and exposure to APPSPIRE modules via an objective measure of general use.

IV. Investigate how feasible the program will be. V. Obtain a maintained use of APPSPIRE with high completeness and extent of completion.

VI. Evaluate change in stage of change from baseline to about 1 and 4-month follow-ups among participants.

OUTLINE:

Participants attend an audio-taped focus group over 1 hour and are given the APPSPIRE app. After 1 and 4 months of using the app, participants complete a telephone survey over 1 hour to discuss how they liked the app and its usefulness.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 38 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: APPSPIRE: Expanding the Reach of an Innovative Tobacco Control Program for Youth
Actual Study Start Date : October 16, 2013
Estimated Primary Completion Date : November 30, 2020
Estimated Study Completion Date : November 30, 2020

Arm Intervention/treatment
Experimental: Prevention (focus group, APPSPIRE app, survey)
Participants attend an audio-taped focus group over 1 hour and are given the APPSPIRE app. After 1 and 4 months of using the app, participants complete a telephone survey over 1 hour to discuss how they liked the app and its usefulness.
Behavioral: APPSPIRE
Given APPSPIRE app
Other Name: APPSPIRE Smartphone Application; APPSPIRE Smartphone App; APPSPIRE App; APPSPIRE Application

Behavioral: Focus Group
Attend focus group

Other: Survey Administration
Complete survey




Primary Outcome Measures :
  1. Frequency of APPSPIRE application (app) use [ Time Frame: Up to 4 months ]
    Will be measured in minutes per day and with descriptive statistics. Will measure using mean, median and standard deviation for continuous variables.

  2. The Feasibility of the tobacco control program. [ Time Frame: Up to 4 months ]
    Feasibly will be measured by multiplying the variable of two concepts: ease of use and ability to fit the program into routine schedules.

  3. The Completeness with the Percentages of Participants surveyed. [ Time Frame: Up to 4 months ]
    Completeness will be measured as the percentage of participants who continue to use AppSPIRE until the 4 month follow up survey.

  4. The extent of completion for the modules AppSPIRE. [ Time Frame: Up to 4 months ]
    The extent of completion includes the various modules of AppSPIRE. High extent of completion is obtained if 75% of the participants have completed all modules of AppSPIRE.

  5. The Stages of the Change Scale [ Time Frame: Baseline up to 4 months ]
    A validated measure, The Stages of Change Scale, will be used to clarify smokers into 3 categories: pre-contemplation, contemplation and preparation.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 24 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Student at Houston Community College (HCC)
  • Speak and read English
  • Own an iPhone
  • Be enrolled in at least one class at HCC
  • Provide current contact information
  • Smoke 1 or more cigarettes a day (cessation group)
  • Have access to the internet (cessation and prevention/advocacy groups)
  • Evidence of smoking susceptibility as defined by the Smoking Susceptibility Scale

Exclusion Criteria:

  • Does not plan to continue as a student at their campus sometime during the year of the study (cessation and prevention/advocacy groups)
  • Current tobacco use (prevention/advocacy group)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01967082


Locations
Layout table for location information
United States, Texas
Houston Community College
Houston, Texas, United States, 77002
M D Anderson Cancer Center
Houston, Texas, United States, 77030
Sponsors and Collaborators
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Institute on Drug Abuse (NIDA)
Investigators
Layout table for investigator information
Principal Investigator: Alexander V Prokhorov M.D. Anderson Cancer Center

Additional Information:
Layout table for additonal information
Responsible Party: M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier: NCT01967082     History of Changes
Other Study ID Numbers: 2013-0369
NCI-2018-03054 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) )
2013-0369 ( Other Identifier: M D Anderson Cancer Center )
P30CA016672 ( U.S. NIH Grant/Contract )
R41DA035012 ( U.S. NIH Grant/Contract )
First Posted: October 22, 2013    Key Record Dates
Last Update Posted: August 20, 2019
Last Verified: August 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No